BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10216105)

  • 21. Role of the molecular staging and response in the management of follicular lymphoma patients.
    Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
    Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.
    Galoin S; al Saati T; Schlaifer D; Huynh A; Attal M; Delsol G
    Br J Haematol; 1996 Sep; 94(4):676-84. PubMed ID: 8826892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources.
    Léonard BM; Hétu F; Busque L; Gyger M; Bélanger R; Perreault C; Roy DC
    Blood; 1998 Jan; 91(1):331-9. PubMed ID: 9414302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma.
    Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF
    Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients.
    Colleoni GW; Duarte LC; Kerbauy FR; Noguti MA; Felix RS; De Oliveira JS; Figueiredo MS; Alves AC
    Leuk Lymphoma; 2004 Mar; 45(3):539-45. PubMed ID: 15160916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene rearrangements in follicular lymphoma among Indonesian.
    Oehadian A; Koide N; Fianza PI; Fadjari TH; Sumantri R; Supandiman I; Yokochi T
    Acta Med Indones; 2006; 38(2):72-6. PubMed ID: 16799206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
    Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
    Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo nodal diffuse large B-cell lymphoma: identification of biologic prognostic factors.
    Abd El-Hameed A
    J Egypt Natl Canc Inst; 2005 Mar; 17(1):20-8. PubMed ID: 16353079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements.
    Jenner MJ; Summers KE; Norton AJ; Amess JA; Arch RS; Young BD; Lister TA; Fitzgibbon J; Goff LK
    Br J Haematol; 2002 Aug; 118(2):550-8. PubMed ID: 12139744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
    López-Guillermo A; Cabanillas F; McLaughlin P; Smith T; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Pugh W; Lee MS
    Ann Oncol; 2000; 11 Suppl 1():137-40. PubMed ID: 10707796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and predictive significance of the bcl-2/IgH translocation in malignant follicular lymphomas.
    Georgescu A; Stoicea M; Comănescu M; Dobrea C; Andrei F; Neagu M; Cionca F; Ciobanu A; Lupu A; Ardeleanu C
    Rom J Morphol Embryol; 2010; 51(4):687-91. PubMed ID: 21103627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct sequence analysis of 14q+ and 18q- chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma.
    Cotter FE; Price C; Meerabux J; Zucca E; Young BD
    Ann Oncol; 1991 Feb; 2 Suppl 2():93-7. PubMed ID: 2049326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance.
    Iqbal S; Jenner MJ; Summers KE; Davies AJ; Matthews J; Norton AJ; Calaminici M; Rohatiner AZ; Fitzgibbon J; Lister TA; Goff LK
    Br J Haematol; 2004 Feb; 124(3):325-8. PubMed ID: 14717779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
    Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
    Ladanyi M; Wang S
    Diagn Mol Pathol; 1992 Mar; 1(1):31-5. PubMed ID: 1342952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
    Larsen CJ; Mecucci C; Leroux D
    Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutation in a case of blastic transformation of follicular lymphoma with double bcl-2 rearrangement (MBR and VCR).
    Nomdedéu JF; Baiget M; Gaidano G; Estivill C; Lasa A; Rubiol E; Mateu R; Bordes R; Brunet S; Saglio G; Soler J
    Leuk Lymphoma; 1998 May; 29(5-6):595-605. PubMed ID: 9643573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.